Literature DB >> 18197188

XLMR genes: update 2007.

Pietro Chiurazzi1, Charles E Schwartz, Jozef Gecz, Giovanni Neri.   

Abstract

X-linked mental retardation (XLMR) is a common cause of inherited intellectual disability with an estimated prevalence of approximately 1/1000 males. Most XLMR conditions are inherited as X-linked recessive traits, although female carriers may manifest usually milder symptoms. We have listed 215 XLMR conditions, subdivided according to their clinical presentation: 149 with specific clinical findings, including 98 syndromes and 51 neuromuscular conditions, and 66 nonspecific (MRX) forms. We also present a map of the 82 XLMR genes cloned to date (November 2007) and a map of the 97 conditions that have been positioned by linkage analysis or cytogenetic breakpoints. We briefly consider the molecular function of known XLMR proteins and discuss the possible strategies to identify the remaining XLMR genes. Final remarks are made on the natural history of XLMR conditions and on diagnostic issues.

Entities:  

Mesh:

Year:  2008        PMID: 18197188     DOI: 10.1038/sj.ejhg.5201994

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  56 in total

1.  Molecular and clinical characterization of a small duplication Xp in a human female with psychiatric disorders.

Authors:  Maria Piccione; Cinzia Sanfilippo; Simona Cavani; Patrizia Salatiello; Michela Malacarne; Mauro Pierluigi; Marco Fichera; Daniela Luciano; Giovanni Corsello
Journal:  J Genet       Date:  2011-12       Impact factor: 1.166

2.  Rapid reversal of impaired inhibitory and excitatory transmission but not spine dysgenesis in a mouse model of mental retardation.

Authors:  Andrew D Powell; Kalbinder K Gill; Pierre-Philippe Saintot; Premysl Jiruska; Jamel Chelly; Pierre Billuart; John G R Jefferys
Journal:  J Physiol       Date:  2011-11-28       Impact factor: 5.182

Review 3.  Epigenetic protein families: a new frontier for drug discovery.

Authors:  Cheryl H Arrowsmith; Chas Bountra; Paul V Fish; Kevin Lee; Matthieu Schapira
Journal:  Nat Rev Drug Discov       Date:  2012-04-13       Impact factor: 84.694

Review 4.  Genetic architectures of psychiatric disorders: the emerging picture and its implications.

Authors:  Patrick F Sullivan; Mark J Daly; Michael O'Donovan
Journal:  Nat Rev Genet       Date:  2012-07-10       Impact factor: 53.242

5.  X-cess of variants in XLMR.

Authors:  David L Nelson; Richard A Gibbs
Journal:  Nat Genet       Date:  2009-05       Impact factor: 38.330

Review 6.  Balanced translocations in mental retardation.

Authors:  Geert Vandeweyer; R Frank Kooy
Journal:  Hum Genet       Date:  2009-04-05       Impact factor: 4.132

7.  Mutations in JARID1C are associated with X-linked mental retardation, short stature and hyperreflexia.

Authors:  F E Abidi; L Holloway; C A Moore; D D Weaver; R J Simensen; R E Stevenson; R C Rogers; C E Schwartz
Journal:  J Med Genet       Date:  2008-08-12       Impact factor: 6.318

8.  MED12 mutations link intellectual disability syndromes with dysregulated GLI3-dependent Sonic Hedgehog signaling.

Authors:  Haiying Zhou; Jason M Spaeth; Nam Hee Kim; Xuan Xu; Michael J Friez; Charles E Schwartz; Thomas G Boyer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

9.  Identification of mutations in TRAPPC9, which encodes the NIK- and IKK-beta-binding protein, in nonsyndromic autosomal-recessive mental retardation.

Authors:  Asif Mir; Liana Kaufman; Abdul Noor; Mahdi M Motazacker; Talal Jamil; Matloob Azam; Kimia Kahrizi; Muhammad Arshad Rafiq; Rosanna Weksberg; Tanveer Nasr; Farooq Naeem; Andreas Tzschach; Andreas W Kuss; Gisele E Ishak; Dan Doherty; H Hilger Ropers; A James Barkovich; Hossein Najmabadi; Muhammad Ayub; John B Vincent
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

10.  A new chromosome x exon-specific microarray platform for screening of patients with X-linked disorders.

Authors:  Stavros Bashiardes; Ludmila Kousoulidou; Hans van Bokhoven; Hans-Hilger Ropers; Jamel Chelly; Claude Moraine; Arjan P M de Brouwer; Hilde Van Esch; Guy Froyen; Philippos C Patsalis
Journal:  J Mol Diagn       Date:  2009-09-24       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.